Wells Fargo’s Arcus Biosciences RCUS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$405K Buy
49,794
+10,603
+27% +$86.3K ﹤0.01% 3929
2025
Q1
$308K Buy
39,191
+573
+1% +$4.5K ﹤0.01% 3975
2024
Q4
$575K Buy
38,618
+19,865
+106% +$296K ﹤0.01% 3624
2024
Q3
$287K Buy
18,753
+139
+0.7% +$2.13K ﹤0.01% 3962
2024
Q2
$283K Sell
18,614
-755
-4% -$11.5K ﹤0.01% 3928
2024
Q1
$366K Buy
19,369
+2,931
+18% +$55.3K ﹤0.01% 3742
2023
Q4
$314K Sell
16,438
-50,022
-75% -$955K ﹤0.01% 3813
2023
Q3
$1.19M Sell
66,460
-9,287
-12% -$167K ﹤0.01% 2971
2023
Q2
$1.54M Sell
75,747
-5,672
-7% -$115K ﹤0.01% 2958
2023
Q1
$1.49M Buy
81,419
+78,312
+2,521% +$1.43M ﹤0.01% 2916
2022
Q4
$64.3K Sell
3,107
-2,795
-47% -$57.8K ﹤0.01% 4449
2022
Q3
$155K Buy
5,902
+154
+3% +$4.04K ﹤0.01% 4087
2022
Q2
$145K Sell
5,748
-23,742
-81% -$599K ﹤0.01% 4196
2022
Q1
$930K Sell
29,490
-13,687
-32% -$432K ﹤0.01% 3723
2021
Q4
$1.75M Buy
43,177
+5,229
+14% +$211K ﹤0.01% 3413
2021
Q3
$1.32M Buy
37,948
+6,515
+21% +$227K ﹤0.01% 3800
2021
Q2
$863K Sell
31,433
-19,598
-38% -$538K ﹤0.01% 4067
2021
Q1
$1.43M Sell
51,031
-57,254
-53% -$1.61M ﹤0.01% 3748
2020
Q4
$2.81M Buy
108,285
+18,287
+20% +$475K ﹤0.01% 3207
2020
Q3
$1.54M Buy
89,998
+1,843
+2% +$31.6K ﹤0.01% 3460
2020
Q2
$2.18M Buy
88,155
+68,606
+351% +$1.7M ﹤0.01% 3158
2020
Q1
$271K Sell
19,549
-1,416
-7% -$19.6K ﹤0.01% 4328
2019
Q4
$212K Buy
20,965
+27
+0.1% +$273 ﹤0.01% 4767
2019
Q3
$191K Sell
20,938
-13,179
-39% -$120K ﹤0.01% 4797
2019
Q2
$272K Sell
34,117
-13,408
-28% -$107K ﹤0.01% 4634
2019
Q1
$593K Sell
47,525
-2,800
-6% -$34.9K ﹤0.01% 4177
2018
Q4
$542K Buy
50,325
+40,165
+395% +$433K ﹤0.01% 4160
2018
Q3
$142K Buy
10,160
+350
+4% +$4.89K ﹤0.01% 4981
2018
Q2
$120K Sell
9,810
-200
-2% -$2.45K ﹤0.01% 5081
2018
Q1
$155K Buy
+10,010
New +$155K ﹤0.01% 4901